C4 Therapeutics Inc (CCCC) financials · rev $35.9M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
C4 Therapeutics Inc (CCCC) rev $35.9M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $35.9M | $35.6M |
| Operating Income | -$115.2M | -$119.6M |
| Net Income | -$105.0M | -$105.3M |
| EPS (Diluted) | -$1.27 | -$1.52 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $359.1M | $349.6M |
| Current Assets | $258.1M | $257.8M |
| Cash & Equivalents | $74.6M | $55.5M |
| PP&E | $4.74M | $5.84M |
| Total Liabilities | $102.5M | $133.6M |
| Current Liabilities | $33.0M | $45.2M |
| Shareholders' Equity | $256.6M | $216.0M |
| Retained Earnings | -$738.7M | -$633.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$98.7M | -$65.2M |
| CapEx | $607.0K | $180.0K |
| Investing Cash Flow | -$8.60M | -$51.3M |
| Financing Cash Flow | $126.4M | $45.3M |
| Net Change in Cash | $19.1M | -$71.1M |
| Free Cash Flow | -$99.3M | -$65.3M |
FAQ
What is CCCC P/E and revenue?
C4 Therapeutics Inc (CCCC) rev $35.9M.
What is CCCC revenue?
C4 Therapeutics Inc last cached revenue is $35.9M (FY2025).
Is CCCC profitable?
C4 Therapeutics Inc last cached net income is -$105.0M (FY2025).
What are CCCC total assets?
C4 Therapeutics Inc last cached total assets are $359.1M (FY2025).
What is CCCC free cash flow?
C4 Therapeutics Inc last cached free cash flow is -$99.3M (FY2025).
Not investment advice. Cached statements, not a live tape.